Profile data is unavailable for this security.
About the company
CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.
- Revenue in HKD (TTM)498.34m
- Net income in HKD-394.54m
- Incorporated2015
- Employees230.00
- LocationCStone Pharmaceuticals1000 Zhangheng Road Bldg 25Pudong New DistrictSUZHOU 200072ChinaCHN
- Phone+86 51 287186550
- Websitehttps://www.cstonepharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sunho Biologics Inc | -100.00bn | -100.00bn | 968.20m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -155.25 | -- | -- | -- |
Jacobio Pharmaceuticals Group Co Ltd | 68.24m | -385.83m | 1.34bn | 301.00 | -- | 1.17 | -- | 19.67 | -0.4991 | -0.4991 | 0.0883 | 1.46 | 0.0419 | -- | 5.21 | 226,723.30 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
Hua Medicine | 82.31m | -226.94m | 1.40bn | 177.00 | -- | 12.00 | -- | 17.06 | -0.2322 | -0.2322 | 0.0842 | 0.1108 | 0.0538 | 1.69 | 13.03 | 465,012.10 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
Wuhan YZY Biopharma Co Ltd | 0.00 | -205.96m | 1.45bn | 123.00 | -- | 10.56 | -- | -- | -1.11 | -1.11 | 0.00 | 0.7075 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.41 | -100.12 | 0.4138 | -- | -- | -- | -1.50 | -- | -- | -- |
Mabpharm Ltd | 93.64m | -224.92m | 1.48bn | 347.00 | -- | 6.74 | -- | 15.85 | -0.0546 | -0.0546 | 0.0227 | 0.0534 | 0.0893 | 0.1176 | 6.02 | 269,863.90 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
TOT Biopharm International Co Ltd | 838.68m | -40.56m | 1.51bn | 551.00 | -- | 2.04 | 287.90 | 1.80 | -0.0559 | -0.0559 | 1.16 | 0.9547 | 0.5808 | 1.87 | 8.03 | 1,522,107.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
CStone Pharmaceuticals | 498.34m | -394.54m | 1.58bn | 230.00 | -- | 3.22 | -- | 3.17 | -0.3128 | -0.3128 | 0.3945 | 0.3822 | 0.2811 | 2.44 | 3.72 | 2,166,678.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
Frontage Holdings Corp | 2.03bn | 84.41m | 1.59bn | 1.76k | 19.10 | 0.5931 | 4.39 | 0.7824 | 0.0409 | 0.0409 | 0.9806 | 1.32 | 0.463 | 60.63 | 5.32 | 1,153,777.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
Immunotech Biopharm Ltd | 0.00 | -359.72m | 1.67bn | 211.00 | -- | 8.97 | -- | -- | -0.699 | -0.699 | 0.00 | 0.3625 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -2.51 | 0.4327 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
Laekna Inc | 0.00 | -396.24m | 1.73bn | 89.00 | -- | 2.00 | -- | -- | -3.28 | -3.28 | 0.00 | 2.21 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
Abbisko Cayman Ltd | 20.48m | -463.68m | 2.09bn | 258.00 | -- | 1.00 | -- | 101.90 | -0.7164 | -0.7164 | 0.0316 | 3.03 | 0.0083 | -- | 1.40 | 79,369.79 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
Alphamab Oncology | 235.04m | -226.25m | 2.21bn | 435.00 | -- | 1.23 | -- | 9.40 | -0.2353 | -0.2353 | 0.2449 | 1.86 | 0.1028 | 0.7705 | 19.34 | 540,329.30 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
Data as of Jul 24 2024. Currency figures normalised to CStone Pharmaceuticals's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 04 Jul 2024 | 17.63m | 1.37% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 9.27m | 0.72% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 8.70m | 0.68% |
Templeton Asset Management Ltd.as of 31 May 2024 | 2.28m | 0.18% |
Dimensional Fund Advisors LPas of 30 Apr 2024 | 439.50k | 0.03% |
Ping An Fund Management Co., Ltd.as of 31 Dec 2023 | 147.50k | 0.01% |
SSgA Funds Management, Inc.as of 03 Jul 2024 | 137.50k | 0.01% |
Vanguard Global Advisers LLCas of 30 Jun 2024 | 59.00k | 0.01% |
DFA Australia Ltd.as of 30 Apr 2024 | 650.00 | 0.00% |
Xinyuan Asset Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 17 Jul 2024Source: FactSet Research Systems Inc.